The search for synergy: a critical review from a response surface perspective.
about
When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transitionNeuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cellsPrediction and assessment of the effects of mixtures of four xenoestrogensEvaluating quantitative formulas for dose-response assessment of chemical mixtures.A critical review of methods for comparing estrogenic activity of endogenous and exogenous chemicals in human milk and infant formula.Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2What is synergy? The Saariselkä agreement revisitedHCV Kinetic Models and Their Implications in Drug DevelopmentViral kinetic modeling: state of the artModelling hepatitis C therapy--predicting effects of treatmentDefining an additivity framework for mixture research in inducible whole-cell biosensors.Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination TreatmentEvaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic feverSynergy Maps: exploring compound combinations using network-based visualizationCombination therapeutics in complex diseasesEfficient discovery of anti-inflammatory small-molecule combinations using evolutionary computingSelective interaction of the human immunodeficiency virus type 1 reverse transcriptase nonnucleoside inhibitor efavirenz and its thio-substituted analog with different enzyme-substrate complexesThe bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxelActivities of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor nelfinavir mesylate in combination with reverse transcriptase and protease inhibitors against acute HIV-1 infection in vitroClinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: analysis of drug interactions and efficaciesImmunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugsSynergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell linesAnalysis of compound synergy in high-throughput cellular screens by population-based lifetime modelingOptimal drug synergy in antimicrobial treatmentsSearch algorithms as a framework for the optimization of drug combinations.Synergistic inhibition of endothelial cell proliferation, tube formation, and sprouting by cyclosporin A and itraconazoleTwo-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinumDrug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxisResource competition may lead to effective treatment of antibiotic resistant infectionsASDCD: antifungal synergistic drug combination databaseReactive oxygen species and autophagy associated apoptosis and limitation of clonogenic survival induced by zoledronic acid in salivary adenoid cystic carcinoma cell line SACC-83Analysis of combination drug therapy to develop regimens with shortened duration of treatment for tuberculosisSynergistic and antagonistic drug combinations depend on network topologyUsing a sequential regimen to eliminate bacteria at sublethal antibiotic dosagesDiscovering anti-platelet drug combinations with an integrated model of activator-inhibitor relationships, activator-activator synergies and inhibitor-inhibitor synergiesEnvironmental Interactions and Epistasis Are Revealed in the Proteomic Responses to Complex StimuliDiscovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical ModelingA Network-Based Target Overlap Score for Characterizing Drug Combinations: High Correlation with Cancer Clinical Trial ResultsSystems Pharmacology and Rational Polypharmacy: Nitric Oxide-Cyclic GMP Signaling Pathway as an Illustrative Example and Derivation of the General CaseHalofuginone Synergistically Enhances Anti-Proliferation of Rapamycin in T Cells and Reduces Cytotoxicity of Cyclosporine in Cultured Renal Tubular Epithelial Cells
P2860
Q21145725-2D8EC693-339F-4B71-BEB0-336BEDFC0883Q24559989-478BC4A9-EB5A-4FB1-961C-DF445E540E95Q24810860-23BF5BBB-A802-4F71-9FC0-83D329BDBEC3Q24812852-62C0D920-0FDA-4A36-A952-9ABCCF1093B9Q24815119-116A5AF5-2A02-469C-964C-20867B19AE00Q26771848-A3034B9E-024D-46B0-BC26-F89144F03872Q26782977-280EFFD7-76A3-41D7-99F8-EE4F7687F3A6Q26801602-2093677B-91F2-4626-A814-2AD1FBFE6DB0Q26824655-99D30911-5D5E-4E95-8F5A-8D530619F562Q26864673-92DC8D90-1ECA-4D36-93EF-34706702FC74Q27305016-21A979A8-6126-4456-AC69-7F195391772EQ27313653-C577A6F0-F9F8-4939-9128-DD4403CCEE14Q27457152-D83DE1B9-9EA9-4133-977F-E1179AE5D9A2Q27902355-070FB4A0-35B4-445D-99D5-911D93E41162Q28076891-069DBFCD-9ECE-4D38-B339-6BC95DE8B035Q28251171-92402418-972C-4DF4-9785-FA98617C1AC5Q28344140-51760164-4D17-4913-912A-66EC682F5AC1Q28362972-58542270-8F15-492A-8217-762046058279Q28379173-E1F0C19A-403F-4541-876C-74BBCBA36845Q28379455-66E06CFF-6123-45F1-8CC5-CF477B0A5A98Q28379457-D3E17F53-C3E8-4F1F-91BB-D02BD4BF9CA3Q28469349-B2BF3554-C2AC-47D5-A03C-9240C26459F9Q28472663-783D2D31-A41D-4351-BEDA-0AACE5561329Q28474170-7D7A5532-886F-4BD9-9EA3-D4295DC251DAQ28474246-45DA1E0A-B47A-4114-AC52-546AF5FFFBCBQ28477256-F22B18A6-EA48-4F37-9367-E8DC5610F517Q28478890-E48CE81D-4B71-4AA0-9C30-8DA74EE3D17AQ28486428-C06AC6C2-3BB1-4BA3-80F4-1862F67618BEQ28537662-3595BA14-8084-451D-B6B0-3B0EC223C290Q28539135-FA67BC18-BFE7-49EC-A94A-C2FEE79D6BE3Q28540022-352CC5C7-E924-4BB4-87F5-6B6AFB3C5475Q28540482-6951A9D8-4DFB-4D87-8AA5-14AEE415789AQ28542101-AB48AD04-982D-4A13-B047-0971FAF99DF4Q28545933-DBC39112-9185-4B3F-B18B-CDDE0687E9B1Q28546587-ADBA8F00-C717-428E-9868-9D75302D5EC9Q28547070-FE74FA29-B277-4434-BBBB-E51DA5274072Q28547862-B7F7725D-BFF7-4564-82A9-031F1FDDB79EQ28547962-206B58C3-E911-4F3E-AF96-B9418B326E0FQ28550867-A977816C-F25C-4EA8-9D6F-6F99197C0A74Q28551630-716BEC11-AC8E-4B1F-8C99-EDBDBF58DF7D
P2860
The search for synergy: a critical review from a response surface perspective.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
The search for synergy: a critical review from a response surface perspective.
@en
type
label
The search for synergy: a critical review from a response surface perspective.
@en
prefLabel
The search for synergy: a critical review from a response surface perspective.
@en
P2093
P1476
The search for synergy: a critical review from a response surface perspective
@en
P2093
P304
P577
1995-06-01T00:00:00Z